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doi:10.1016/j.ejvs.2009.02.017Abstract Objectives: Aorto-iliac angulations may be challenging for modular stent-graft
systems (SGSs) from a single manufacturer. This study aims to define the pullout forces (POFs)
of SGSs derived from the same (non-hybrid) or different manufacturers (hybrid).
Methods: The POFs were tested in a vertical position in air and 5% albumin. We studied the
POFs between legs from Anaconda (Vascutek), Excluder (Gore), Talent (Medtronic) and
Zenith (Cook) with the contralateral limb of bifurcated aortic bodies from Zenith (12 mm),
Anaconda and Excluder.
Results: For non-hybrid SGSs, the POFs decreased in the following order: Anaconda
(11.2  0.6 N), Talent (6.25  0.6 N), Zenith (3.5  0.01 N) and Excluder (2.5  0.5 N). The
Zenith body with the Anaconda limb (15 mm) registered the greatest POF (13.083 0.821 N);
the Zenith and Excluder bodies combinedwith the Excluder limb (16 mm) registered theweakest
POFs (2.397 0.22 N and 2.500 0.479 N, respectively). The Zenith body combined with the
Excluder limb (16 mm) had a POF similar to the Zenith non-hybrid; combined with Talent
14 mm and Anaconda limb exhibited POFs greater than the Zenith non-hybrid system. For the
limb-to-limb POFs, the greatest was registered for the Anaconda limb, 13 mm within a 12-mm
extension for 40-mm overlaps (23.06  0.480 N); the weakest POFs were recorded for the
Excluder limbs at 30-mm overlaps (1.09 0.167 N and 1.11 0.250 N).
Conclusions: The hybrid SGSs performed as well as or better than the non-hybrid systems, and
should be considered for clinical testing in patients whose unique anatomy warrants the
flexibility that the use of hybrids provides.
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672 D.P. Cina` et al.IntroductionFigure 2 Intraoperative angiogram of the same patient in
Fig. 1, in whom the aneurysm was treated with a hybrid stent-
graft system made of a Zenith Cook body and an Anaconda
Vascutek limb.Endovascular aneurysm repair (EVAR) has become a standard
of care, capturing an estimated 40e70% of all elective
abdominal aortic aneurysm (AAA) interventions in the
USA.1e5 Themost commonendograft design ismodular, using
a body and one or two limbs. This constitutes a non-hybrid
stent-graft system (NHSGS), which is usually supplied by
a single manufacturer, and which has undergone individual
unit and full-system testing to achieve regulatory certifica-
tion.6 To use any particular NHSGS, however, the patient’s
anatomymust fall within a certain set of parameters for safe
use. Unfortunately, some individuals have anatomical
features that prevent the use of EVAR with the currently
available NHSGS. Applicability of EVAR is therefore still
limited by the incompatibility of anatomical variables and
the design characteristics of different types of endografts.7,8
In particular, aorto-iliac angulations and iliac artery tortu-
osities may be challenging for some available NHSGS. To
overcome these difficulties and take advantage of different
product characteristics, a recent trend has been for clinical
practitioners to assemble endografts from different manu-
factures to create an anatomically compatible hybrid stent-
graft system (HSGS) (Figs. 1 and 2).7 Literature suggests that
combinations of this type are used in about 7.9% of cases,7,9
but this is likely an underestimate.
Manufacturers perform physical testing of NHSGS,
following a protocol laid out by the International Organiza-
tion for Standardization (ISO),10 which includes pullout
forces (POFs), to submit for regulatory approval. There are
limited studies addressing the stability of HSGS and, in
particular, the mechanical properties of the overlapping
section (‘docking zone’). This lack of information is particu-
larly troubling in the light of concerns raised in the past few
years by theUS Food andDrugAdministration (FDA) regarding
problems that have surfaced from the routine use of drug-
eluting and biliary stents for off-label indications.11,12 TheFigure 1 3-D rendering of computerized tomography
showing hostile iliac anatomy.increase in the use and promotion of off-label drugs and
mechanical devices is an issue that the FDA is becomingmore
and more concerned about. Thus the need to perform
appropriate studies to evaluate off-label device safety and
behaviour has become even more critical.
The most common long-term endoleaks requiring urgent
re-intervention with stent grafts used for EVAR are graft
migration (type 1) and limb separation (type 3).13,14 This is
thought to be caused by the repeated stress applied to the
stent graft by the pulsatile blood flow,15 although with
large sac aneurysms, pressure changes resulting from
postoperative sac shrinkage can also cause stent-graft
movement and separation of the modular components.16
Because endografts are poorly incorporated into the
patient’s vessels, they resist dislodgement primarily
through mechanical forces at the landing zones and radial
and frictional forces at the docking zones. We hypothesised
that great variations exist among the NHSGSs from different
manufacturers in their ability to withstand POFs at the
docking zones and that some HSGS combinations can
withstand greater forces.
Since no data are available regarding the physical
properties of these HSGSs, the objective of this study is to
report a standardized test protocol to study the POFs and to
compare the results obtained for modular NHSGSs with
those of HSGSs.
Materials and Methods
Endografts and experimental setup
Basedoncommercial availability, stents fromfour companies
were used in this study: Anaconda (Vascutek, Inchinnan,
Renfrewshire, Scotland); Zenith and helical iliac branched
graft (Cook Medical Inc., Bloomington, IN, USA); Excluder
Table 2 Limb extension to limb extension tests.
Limb extension (mm)
Anaconda Excluder Talent Zenith
Anaconda 10-9
11-10
12-11
12-12
13-12
15-12
Excluder 16-16
Talent 14-14
Zenith 12-12
Pullout Forces of Hybrid Endografts 673(W. L. Gore and Associates, Newark, DE, USA) and Talent
(Medtronic Inc., Minneapolis, MN, USA).
We studied the POFs using limb extensions from
Anaconda (Vascutek) (12, 13 and 15 mm in diameter),
Excluder (Gore) (16 mm), Talent (Medtronic) (14 mm)
and Zenith (Cook) (12 mm); a helical iliac branched graft
(IBG) (Cook) and bifurcated aortic bodies from Excluder
(Gore), Talent (Medtronic) and Zenith (Cook) (contra-
lateral limb diameter 13, 14 and 12 mm, respectively). We
also used two different body diameters (28 and 30 mm) for
the Anaconda (Vascutek) system with contralateral limb
diameters of 11.5 and 12.5 mm, respectively.
For the bifurcated bodies, we studied the POFs between
the contralateral limb and a limb extension using an overlap
of 30 mm. Based on availability, on clinical rationale and
suggested combinations from manufacturers, we tested the
non-hybrid and hybrid configurations as described in
Table 1.
The POFs of limb extension to limb extension were
studied with 30-mm and 40-mm overlaps for the combina-
tions described in Table 2.
We also tested the POFs between the 17-mm long
(12 mm in diameter) proximal stent of the helical IBG and
the Anaconda limbs (13 mm and 15 mm) and the Zenith limb
extension of 12 mm. For these tests, the overlap was
limited to 17 mm.
Ineachcase, theprecisedegreeofoverlapwasestablished
by transparency, using a back-lit table and a metal ruler and
callipers (Fig. 3). All the POFmeasurements were conducted
with theelements ina verticalposition and repeated thrice in
an environmental chamber at room temperature.
Test media
In this study, we hypothesised that the POFs are greater in
liquid solution than in a dry environment. The ISO standards
used a water bath, but we postulated that the POFs in
water would not be representative of what occurs in vivoTable 1 Bifurcated body and limb extensions for non-
hybrid and hybrid configurations tested.
Contralateral limb of
bifurcated body (mm)
Limb (mm)
Anaconda Excluder Talent Zenith
Anaconda (11.5) 12 16 14 12
13
15
Anaconda (12.5) 13 14 12
15
Excluder (13) 13 16
15
Zenith (12) 12 16 14 12
13
15
Talent (14 mm) 12 16 14 12
13
15since whole blood has a relative viscosity three times
greater than water. The coefficient of viscosity of water is
0.001 N s1 m2 at 20 C, and of whole blood is
0.0027 N s1 m2 at 37 C.17,18 The viscosity of human
albumin (5%) has been reported to be between 0.0035 and
0.0040 N s1 m2.19 In view of the greater similarity
between the viscosity of whole blood and a 5% albumin
solution with an approximate sodium content of
145 mEq l1, we chose this medium for testing (Plasbumin-
5, Talecris Biotherapeutics, Inc., Research Triangle Park,
NC, USA), and also used air as the reference.
Test apparatus
A custom apparatus comprising of a software and hardware
was designed and constructed to ensure uniformity of
testing and efficiency.
The frame, made from an acrylic polymer, supported
a cylinder containing the albumin solution, into which the
stents were submerged (Fig. 4). An anchor point at the
bottom of the test vessel fixed the distal stent, and a wire
attached to an electronic FT24 tension load cell (MSI
sensors, Measurement Specialties, Inc., Hampton, VA, USA)
held the proximal stent. The tension load cell, which
recorded the measurements of force with a resolution of
0.04 N, was connected to the spool of an electric motor
used to apply variable forces to the stents.
An electronic control and data acquisition system based
on an Atmega168 micro-controller (Atmel Corporation, San
Jose, CA, USA) regulated the force applied by the electric
motor, while continuously recording the force values from
the load cell. The electronic unit detected pullouts through
digital signal processing and transmitted the recorded
forces back to a computer via a USB connection. Custom-
designed software recorded the maximum force
experienced during a test into a database as the POF.
The proximal docking zone of the distal stent graft was
deployed 30 mm (or 40 mm, for limb-to-limb tests; 17 mm
for helical IBG) into the distal docking zone of the proximal
stent. Steel wires were affixed to the non-docking zone
ends of each endograft in a manner that evenly distributed
the force applied by the electric motor. The wire also
provided an attachment point for anchoring.
Once the stents were loaded in the cylinder, the test
fixture applied a constantly increasing force to the proximal
Figure 4 Test apparatus: the frame supports a cylinder
containing the albumin solution, into which the stent is
submerged. An anchor point at the bottom of the cylinder fixes
the distal stent, and the proximal stent is held by a wire
attached to the electronic tension load cell. The latter is
connected to the spool of the electric motor applying variable
forces to the stents.
Figure 3 Technique of measurement of the overlap between
the body and the extension of a stent-graft system.
674 D.P. Cina` et al.stent, while the distal stent graft remained fixed to the
bottom of the apparatus. The motor continued to increase
the applied force until the proximal and distal stent grafts
were disconnected. The software recorded the maximum
force measured over the course of the test as the POF.
Statistical analysis
Data were expressed as mean and standard deviation
(unless specified). Continuous variables were compared by
Student’s t-test or analysis of variance (ANOVA) and post-
hoc analyses with Tukey’s correction using SPSS (SPSS v. 16
Inc., 2007, Chicago, IL, USA). P-values 0.05 were consid-
ered statistically significant. Graphical representation of
data was done using SPSS and Microsoft Excel 2008 (Micro-
soft Corporation, 2007, Santa Rosa, CA, USA).
Results
When all the tests were considered, the POFs in albumin
solutions were greater than in the air environment
(8.494 5.485 vs. 7.906 4.236 N, PZ 0.006).
Body with limb extensions
The POFs in albumin solution and in the dry environment for
NHSGS and HSGS combinations of body with limb extensions
are described in Tables 3 and 4.
Non-hybrid stent-graft systems
Among the NHSGSs, the POFs were significantly greater in
the Anaconda system compared with all other SGSs
(P< 0.001); greater for the Talent system compared with
the Zenith and the Excluder systems (P< 0.001) and greater
for the Zenith system compared with the Excluder system,
but the latter difference did not reach statistical
significance (PZ 0.07) (Fig. 5).
Hybrid stent-graft systems
The Zenith, Anaconda 28 and Anaconda 30 bodies combined
with the Anaconda limb extension of 15 mm registered thegreatest POFs: 13.083 0.821, 12.957 0.443 and
12.503 0.413 N, respectively, without statistical differ-
ence among them. The weakest POFs were recorded with
Talent, Zenith and Excluder bodies combined with the
Excluder limb extension 16 limb, 2.03 0.3, 2.397 0.22
and 2.500 0.479 N, respectively, without statistical
difference among them. When the Zenith limb extension
(12 mm) was combined with the Talent or Zenith body,
there was no difference in the POFs (PZ 0.468), nor when
the Zenith limb was combined with the Anaconda 28 and 30
bodies (PZ 0.683). The latter two combinations, however,
exhibited greater POFs than the hybrid with the Talent and
Zenith bodies.
The HSGS using an Anaconda 28 body with Excluder
(16 mm), Talent (14 mm) or Zenith (12 mm) exhibited POFs
which were weaker than the Anaconda 28 non-hybrid
system with a 13-mm diameter limb. The HSGS using an
Excluder body with an Anaconda limb (15 mm) had a POF
more than twice that of the non-hybrid Excluder system.
The Zenith body combined with an Excluder limb extension
(16 mm) had a POF similar to the Zenith non-hybrid;
combined with the Talent (14 mm) and Anaconda limb
extensions (12, 13 and 15 mm) exhibited POFs greater than
the Zenith non-hybrid system (Fig. 6).
Table 3 Pullout forces in albumin solution for non-hybrid and hybrid combinations of body with limb extensions.
Body (contralateral limb diameter, mm)
Limb extensions
(diameter, mm)
Talent (14) Zenith (12) Excluder (13) Anaconda 28 (11.5) Anaconda 30 (12.5)
Talent (14) 6.250 0.573a 6.360 0.139a e 5.643 0.289 5.287 0.300
Zenith (12) 3.613 0.269b 3.493 0.098b e 2.540 0.242c,g 2.467 0.150c
Excluder (16) 2.033 0.277d 2.397 0.222d 2.500 0.479d 3.157 0.134g e
Anaconda (12) 8.047 0.981 5.187 0.501e e 5.077 0.647e e
Anaconda (13) 9.63 0.352 8.060 0.250 1.490 0.066 11.19 0.606 4.720 0.383
Anaconda (15) 11.397 0.733 13.083 0.821f 4.910 0.259 12.957 0.443f 12.503 0.413f
Comparisons of all groups across columns and rows by ANOVA were all statistically significant (P< 0.001). Tukey’s adjusted post-hoc
t-test was used for comparison between groups. The same symbol between two comparisons denotes absence of a statistical significant
difference. All other comparisons were statistically significantly different (P 0.05).
a Talent 14 limb combined with Talent body and with Zenith body (PZ 0.716).
b Zenith 12 limb combined with Talent body and Zenith body (PZ 0.468).
c Zenith 12 limb combined with Anaconda 28 body and Anaconda 30 body (PZ 0.683).
d Excluder 16 limb combined with Zenith body and Excluder body (PZ 0.695).
e Anaconda 12 limb combined with Zenith body and Anaconda 28 body (PZ 0.860).
f Anaconda 15 limb combined with Zenith body and Anaconda 28 body (PZ 0.796), or Anaconda 30 body (PZ 0.244).
g Anaconda 28 body with Zenith 12 limb and Excluder 16 limb (PZ 0.107).
Pullout Forces of Hybrid Endografts 675Limb-to-limb pullout forces
Limb-to-limb combinations were only tested for NHSGS
devices and the results are summarised in Tables 5 and 6. The
cumulative POFs of limb-to-limb extensions were greater for
40- than for 30-mm overlaps (P< 0.01). When looking at the
individual devices, the POFs of limb-to-limb extensions were
also greater for 40- than for 30-mm overlaps, with the
exception of the Excluder limb extension (PZ 0.9).
The greatest POF was registered for the Anaconda limb
extension 13 mm within a 12-mm extension and for an over-
lap of 40 mm (23.06 0.480 N). The weakest were recorded
for the Excluder limb extension at 30- and 40-mm overlaps
(1.09 0.167 N and 1.11 0.250 N, respectively). When anTable 4 Dry pullout forces for non-hybrid and hybrid combinat
Body (contralateral limb diameter, mm)
Limb extensions
(diameter, mm)
Talent (14) Zenith (12) Ex
Talent (14) 6.650 0.500 7.603 0.432g
Zenith (12) 4.884 0.06 4.166 0.313
Excluder (16) 2.281 0.123h,i 2.393 0.105h 1.
Anaconda (12) 8.182 0.149 4.953 0.395
Anaconda (13) 10.073 0.063 8.541 0.191 2.
Anaconda (15) 11.784 0.299d 13.095 0.133e,f 5.
Comparisons of all groups across columns and rows by ANOVA were al
test was used for comparison between groups. The same symbol betw
All other comparisons were statistically significantly different (P 0.
a Anaconda 28 body combined with Talent 14 mm limb or Anaconda
b Anaconda 28 body combined with Zenith 12 mm limb or Excluder
c Excluder body combined with Excluder 16 mm limb or Anaconda 1
d Anaconda 15 mm limb combined with Talent body or Anaconda 30
e Anaconda 15 mm limb combined with Zenith body or Anaconda 28
f Anaconda 15 mm limb combined with Zenith body or Anaconda 30
g Talent 14 mm limb combined with Zenith body or Anaconda 28 body
combined with Anaconda 28 body or Anaconda 30 body (PZ 0.254).
h Excluder 16 mm limb combined with Talent body or Zenith body (
i Excluder 16 mm limb combined with Talent body or Excluder bodyAnaconda limb extension was inserted within another of
smaller diameter (10 to 9 mm; 11 to 10 mm; 12 to 11 mm and
12 to 12 mm), the POFs increased predictably up to a certain
diameter of oversizing, beyond which the POF decreased (13
to 12 mm and 15 to 12 mm) (Fig. 7, Tables 5 and 6).
Helical IBG
The POFs between the helical IBG and the limb extensions
were 4.78 0.24 N for the Anaconda (13 mm),
3.95 0.17 N for the Anaconda (15 mm) and 4.58 0.28 N
for the Zenith limb extension. The POFs were greater using
Anaconda (13 mm) vs. Anaconda (15 mm) (PZ 0.005) and
Anaconda (15 mm) vs. Zenith (12 mm) (PZ 0.017) (Fig. 8).ions of body with limb extensions.
cluder (13) Anaconda 28 (11.5) Anaconda 30 (12.5)
e 6.609 0.166a,g 6.029 0.149g
e 3.228 0.063b 2.386 0.041
866 0.285c,i 3.154 0.124b e
e 6.209 0.521a e
400 0.048c 11.894 0.686 4.815 0.212
063 0.417 13.7298 0.041e 12.322 0.432d,f
l statistically significant (P< 0.001). Tukey’s adjusted post-hoc t-
een two comparisons denotes absence of a statistical difference.
05).
12 mm limb (PZ 0.753).
16 mm limb (PZ 1.000).
3 mm limb (PZ 0.143).
body (PZ 0.271).
body (PZ 0.158).
body (PZ 0.68).
(PZ 0.999), or Anaconda 30 body (PZ 0.209); Talent 14 mm limb
PZ 0.861).
(PZ 0.076).
Figure 5 Wet pullout force for non-hybrid body-to-limb extension modular endografts. Each of the Anaconda bodies (28 and 30)
was tested with the recommended limb diameters of 13 mm and 15 mm, respectively.
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We have shown that the POFs are greater in albumin solution
than in adry environment. In selecting afluid as themedia for
POFs, we excluded water because blood has a much higher
viscosity. We considered human blood, equine blood, equine
albumin, porcine blood and porcine albumin, as well as an
artificial blood solution.20e23 Human or porcine blood would
have been the ideal medium due to their similarities.24,25
Availability and cost, however, were a concern. In addition,
whole blood has several drawbacks: it coagulates once
exposed to air, affecting the test environment and poten-
tially damaging the stents; the use of anticoagulants may
alter the physical properties of blood in unpredictable waysFigure 6 Wet pullout forces for hybrid body-to-limb extension m
the recommended limb diameters of 13 mm and 15 mm, respectivand finally the physical characteristics of human blood can
vary from one sample to the next.26 Because of these
considerations and the fact that the primary protein of serum
is albumin, we chose a 5% albumin solution.
Body-to-limb extensions
There is a great variation in the POFs among different
manufacturers: for body-to-limb (2e13 N) and for limb-to-
limb extensions (1e5 N). For NHSGS, the POFs decrease
progressively in the following order: Anaconda, Talent,
Zenith and Excluder systems (Fig. 5). High POFs (greater
than 6 N) are recorded with hybrids of a Talent body with
Excluder and Anaconda limbs or Zenith body with Anacondaodular endografts. The Anaconda body 28 mm was tested with
ely.
Table 5 Pullout forces in albumin solution for limb extension to limb extension combinations for overlaps of 30 mm and
40 mm.
Limb extension (mm) Overlap
30 mm 40 mm
Anaconda (10)/Anaconda (9) 12.83 0.52 16.53 0.024
Anaconda (11)/Anaconda (10) 12.13 0.393 13.28 0.587c
Anaconda (12)/Anaconda (11) 13.98 0.271 17.52 0.606
Anaconda (12)/Anaconda (12) 13.58 0.643a 19.19 0.313
Anaconda (13)/Anaconda (12) 14.01 0.408a 23.06 0.480
Anaconda (15)/Anaconda (12) 9.19 0.345 13.18 0.235c
Excluder (16)/Excluder (16) 1.09 0.167x 1.11 0.250x
Talent (14)/Talent (14) 4.08 0.149b 5.52 0.172
Zenith (12)/Zenith (12) 4.30 0.443b 4.61 0.402
Comparisons of all groups across columns and rows by ANOVA were all statistically significant (P< 0.001). Tukey’s adjusted post-hoc t-
test was used for comparison between groups. The same symbol between two comparisons denotes absence of a statistical significant
difference. All other comparisons were statistically significantly different (P 0.05).
a Anaconda (12)/Anaconda (12) and Anaconda (12)/Anaconda (12) (PZ 0.208).
b Talent (14)/Talent (14) and Zenith (12)/Zenith (12) (PZ 0.509).
c Anaconda (11)/Anaconda (10) and Anaconda (15)/Anaconda (12) (PZ 0.731).
Pullout Forces of Hybrid Endografts 677limbs. Hybrids using an Anaconda body with Excluder or
Talent limbs and an Excluder body with appropriately sized
Anaconda limbs (15 mm) have POFs lower than the former
groups but in the range of or greater than the non-hybrid
Zenith and Excluder. All hybrids of a Zenith body have high
POFs except the one using an Excluder limb (Fig. 6). The
greatest POFs were found for Zenith, Anaconda 28 and 30
bodies with Anaconda limbs (15 mm) (12e13 N). The
weakest POFs were identified with Excluder and Zenith
bodies combined with the Excluder limb (16 mm)
(1.8e2.5 N).Table 6 Dry pullout forces for limb extension to limb extension
Limb extension (mm) Ove
30 m
Anaconda (10)/Anaconda (9) 13.2
Anaconda (11)/Anaconda (10) 8.3
Anaconda (12)/Anaconda (11) 10.2
Anaconda (12)/Anaconda (12) 11.3
Anaconda (13)/Anaconda (12) 10.8
Anaconda (15)/Anaconda (12) 10.5
Excluder (16)/Excluder (16) 0.4
Talent (14)/Talent (14) 3.6
Zenith (12)/Zenith (12) 3.8
Comparisons of all groups across columns and rows by ANOVA were all s
was used for comparison between groups. The same symbol betwee
difference. All other comparisons were statistically significantly diffe
a At a 30 mm overlap, Talent (14)/Talent (14) and Zenith (12)/Zenit
b At a 30 mm overlap, Anaconda (12)/Anaconda (11) vs. Anaconda (13
(PZ 0.949); at a 30 mm overlap, Anaconda (13)/Anaconda (12) vs. An
c At a 30 mm overlap, Anaconda (12)/Anaconda (12) vs. Anaconda (
d At a 30 mm overlap, Anaconda (12)/Anaconda (12) vs. Anaconda (
e At a 40 mm overlap, Talent (14)/Talent (14) and Zenith (12)/Zenit
f At a 40 mm overlap, Anaconda (12)/Anaconda (11) vs. Anaconda (
g At a 40 mm overlap, Anaconda (12)/Anaconda (11) vs. Anaconda (13
(PZ 0.773); at a 40 mm overlap, Anaconda (13)/Anaconda (12) vs. AnLimb-to-limb extensions
When considering limb-to-limb POFs, these were predict-
ably greater for 40-mm overlaps compared with 30 mm. An
exception was the Excluder limbs which exhibited POFs
which were the lowest of the group and not different for
30- and 40-mm overlaps. The Zenith and Talent limbs per-
formed very similarly, and the Anaconda limbs displayed
the greatest POFs. For Excluder, Zenith and Talent, an
overlap of 30e40 mm is probably advisable, while for
Anaconda limbs where POFs are very high, shorter overlapscombinations for overlaps of 30 mm and 40 mm.
rlap
m 40 mm
9 0.415 16.0344 0.908e
2 0.599 10.8318 0.313e
1 0.190b 13.5504 0.235g,f
8 0.443c,d 14.5716 0.373f
2 0.145b,c 12.3084 0.701g
6 0.276b,d 12.9432 0.361g
3 0.024 0.5646 0.072
6 0.313a 4.6356 0.291
1 0.425a 4.7598 0.157
tatistically significant (P< 0.01). Tukey’s adjusted post-hoc t-test
n two comparisons denotes absence of a statistically significant
rent (P 0.05).
h (12) (PZ 0.1.00).
)/Anaconda (12) (PZ 0.508); or vs. Anaconda (15)/Anaconda (12)
aconda (15)/Anaconda (12) (PZ 0.990).
13)/Anaconda (12) (PZ 0.543).
15)/Anaconda (12) (PZ 0.167).
h (12) (PZ 1.00).
12)/Anaconda (12) (PZ 0.196).
)/Anaconda (12) (PZ 0.067); or vs. Anaconda (15)/Anaconda (12)
aconda (15)/Anaconda (12) (PZ 0.732).
Figure 7 Pullout forces in albumin solution for the 30-mm and 40-mm overlap of each limb system.
678 D.P. Cina` et al.may be adequate, although this assumption was not tested.
In addition, the overall effect of limb separation is the
result of the direct POFs at the level of the ‘docking zones’
and of the distribution of the forces derived from the
pulsatile blood flow over the entire length of the stent.
Since the Anaconda limbs do not have longitudinal support,
it is the docking zone that may bear the brunt of the
pulsatile force, while stents with greater longitudinal
strength (e.g., Talent and Zenith) need to resist less force
at the docking zone, because more of that force might be
absorbed by the distal elements of the structure.Fish mouthing
When an Anaconda limb was inserted within another of
smaller diameter, the POF increased predictably up to
a certain diameter of oversizing, beyond which the POF
decreased. That the most extreme oversizing does not
necessarily result in the highest POFs has been recognised
in vivo.16,27 When the Anaconda limbs are greatly over-
sized, as with the 15 mm in the 12 mm, the rings do not
fully return to their circular shape, acquiring a fish-mouth
shape. We hypothesise that, in this setting, the rings do not
interlock and the POF is reduced.
In only one reported instance,28 the POFs were tested
in a manner similar to ours, however, using water as a test
medium. Two of the stents tested are not available for use
any longer (the AneuRx and the Fortron); for the Zenith
device they used a BiFab aorto-uni configuration with
a limb overlap much greater that 30 mm and predictably
recorded average POFs greater than ours (7 N vs. 5 N); for
the Talent stent graft they used a bifurcate configuration
and the recommended overlap of 30 mm. They found
average POFs of 5.5 N, somewhat lower than ours (7 N)
likely due to the different test medium (water vs.
albumin). They did not however test any hybrid configu-
ration. When manufacturers perform similar testing tosubmit for regulatory approval, they follow a protocol laid
out by the ISO,10 but the results are not easily available for
review.
We established a protocol for testing the POFs that
includes four significant changes from earlier studies by
others and from the ISO standards: (1) non-realistic test
media (water, air, etc.) were replaced with a 5% human
albumin solution, which more accurately replicates in vivo
demands upon a stent graft once inserted; (2) all models
were adjusted, using callipers and a back-lit light table, to
a standardized docking zone overlap within the manu-
facturer’s recommended range (generally 30 mm, also
40 mm for limb-to-limb tests; 17 mm for Cook’s helical IBG)
prior to testing; (3) vertically oriented testing, with the SGS
suspended in the test medium, simulates a sitting or
standing position; (4) testing of HSGSs in addition to non-
hybrid, single-manufacturer SGS systems. We were able to
obtain results for ISO standard testing from Vascutek with
respect to the body-to-limb POFs: for the body size 28
matched with a limb 13 mm in diameter and a body size 30
matched with a limb 15 mm in diameter (recommended
manufacturer combinations) the POFs were 10.0 2.9 and
10.1 2.6 N, respectively. For the same combinations in
our testing protocol, the results were 11.2 0.6 and
12.5 0.4 N, respectively. The difference was significantly
different statistically (P< 0.01). This difference is in
keeping with the theoretical construct that the POFs in
a more viscous liquid environment are greater than
in water.
We identify two primary results of this research that
should be taken into account when designing human clinical
trials to evaluate the compatibility of stent-graft compo-
nents in a hybrid system. First, care should be taken when
considering the use of any HSGSs that have particularly low
POFs in preliminary physical testing such as ours. Second,
since HSGS in our tests performed as well as or better than
the homogeneous systems, hybrid systems are definitely
worth studying, especially with regard to choosing the
Figure 8 Pullout forces of the helical iliac branched graft
with Anaconda limb extension 13 mm, 15 mm and Zenith
12 mm limb extensions using a 17-mm overlap. Pullout forces
were greater using Anaconda 13 mm vs. Anaconda 15 mm
(PZ 0.005); and Anaconda 15 mm vs. Zenith 12 mm
(PZ 0.017).
Pullout Forces of Hybrid Endografts 679optimal mix of stable HGS components to match unique
patient anatomies.
The limitations of this study are that it is a physical study
of POF with no clinical correlation with type 3 endoleaks;
the peak POF was used instead of the area under the curve
which is a measure of the overall energy of displacement;
a limited number of possible combinations was investi-
gated; and we did not conduct a study of the diameter of
luminal encroachment. Type 3 endoleaks are the result of
complex interactions between many different factors,
some not yet identified, and many not well understood. On
the basis of theoretical constructs, however, low POFs are
one significant contributing factor.
Physical studies of endovascular stent-graft systems are
used according to the ISO before regulatory approval for
any device. The results of this study should not be consid-
ered an endorsement of or warning against any particular
combination (hybrid or otherwise). However, since there
are virtually no studies addressing the hybrid systems, we
feel that our work is relevant for the researcher, clinician
and regulatory bodies; the researcher who embarks on
endovascular graft development and testing may want toconsider our technique of physical testing, and consider the
medium in which these tests are done, since currently the
ISO uses water and the horizontal position for POFs, while
perhaps a fluid more compatible with blood and a vertical
position (as we have done) may be more appropriate; the
clinician, who would like to use a hybrid system to better fit
his patient’s anatomy, may find himself asking the ques-
tions, ‘If I were to use a body supplied by one manufacturer
and a limb of another, what is the overlap I should use?’
‘What is the oversizing? How does my choice impact on the
POFs compared with the non-hybrid system?’ The regula-
tory agencies may also consider asking manufacturers for
different ways of testing the physical properties of modular
SGSs.
Conclusion
Hybrid and non-hybrid SGSs exhibited POFs which were
similar when appropriate oversizing was used. HSGS should
be considered for clinical testing in patients whose unique
anatomy warrants the flexibility that their use provides.
When considering the use of HSGS in such trials, combina-
tions with very low POFs should be balanced against the
potentially increased risk of type 3 endoleaks.
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